41 related articles for article (PubMed ID: 20858319)
1. [Medullary thyroid cancer, a tumour with many appearances].
Verbeek HH; de Groot JW; Plukker JT; Hofstra RW; Brouwers AH; Kerstens MN; Links TP
Ned Tijdschr Geneeskd; 2010; 154():A1818. PubMed ID: 20858319
[TBL] [Abstract][Full Text] [Related]
2. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
3. [Lump in the neck: 4 patients with a medullary thyroid carcinoma].
Jansen M; Jansen-Schillhorn van Veen JM; Vroom TM; van Vroonhoven TJ; Lips CJ
Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2234-41. PubMed ID: 11757248
[TBL] [Abstract][Full Text] [Related]
4. Medullary thyroid carcinoma (MTC)--clinical and molecular aspects on the basis of own experience.
Pomorski L; Bartkowiak J; Pisarek H; Bartos M; Narebski J
Neoplasma; 2000; 47(5):323-6. PubMed ID: 11130252
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
6. Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies.
Kim JM; Chung KW; Kim SW; Choi SH; Min HS; Kim JN; Won WJ; Kim SK; Lee JI; Chung JH; Kim SW
Head Neck; 2010 Jan; 32(1):68-75. PubMed ID: 19536770
[TBL] [Abstract][Full Text] [Related]
7. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
8. Medullary thyroid cancer: early detection and novel treatments.
Roman S; Mehta P; Sosa JA
Curr Opin Oncol; 2009 Jan; 21(1):5-10. PubMed ID: 19125012
[TBL] [Abstract][Full Text] [Related]
9. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
[TBL] [Abstract][Full Text] [Related]
10. MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
Castellani MR; Seregni E; Maccauro M; Chiesa C; Aliberti G; Orunesu E; Bombardieri E
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):430-40. PubMed ID: 19088696
[TBL] [Abstract][Full Text] [Related]
11. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of medullary thyroid carcinoma.
Massoll N; Mazzaferri EL
Clin Lab Med; 2004 Mar; 24(1):49-83. PubMed ID: 15157557
[TBL] [Abstract][Full Text] [Related]
13. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
Skinner MA; Wells SA
Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
[TBL] [Abstract][Full Text] [Related]
14. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
[TBL] [Abstract][Full Text] [Related]
15. CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo.
Antonelli A; Bocci G; La Motta C; Ferrari SM; Fallahi P; Corrado A; Fioravanti A; Sartini S; Orlandi P; Piaggi S; Corti A; Materazzi G; Galleri D; Ulisse S; Fontanini G; Danesi R; Da Settimo F; Miccoli P
Mol Cell Endocrinol; 2014 Aug; 393(1-2):56-64. PubMed ID: 24931161
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of thyroid nodules via real-time PET/ultrasound (US) fusion in a case of co-existing medullary thyroid cancer and adenoma.
Gühne F; Winkens T; Mothes H; Freesmeyer M
J Clin Endocrinol Metab; 2013 Nov; 98(11):4250-1. PubMed ID: 24001745
[No Abstract] [Full Text] [Related]
17. Medullary thyroid carcinoma (MTC): unusual metastatic sites.
Kazakou P; Simeakis G; Alevizaki M; Saltiki K
Endocrinol Diabetes Metab Case Rep; 2021 Sep; 2021():. PubMed ID: 34551391
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Dilemma in a Thyroid Incidentaloma: Second Primary versus Metastatic Nodule?
Mirza AA; Pai E; Srinivas KG; Amarendra S; Gopinath KS
J Clin Diagn Res; 2016 Jun; 10(6):PD10-2. PubMed ID: 27504349
[TBL] [Abstract][Full Text] [Related]
19. Breast Metastasis from Medullary Thyroid Carcinoma in a Male Patient: Case Report and Review of the Literature.
Mandanas S; Margaritidou E; Christoforidou V; Karoglou E; Geranou C; Chrisoulidou A; Boudina M; Georgopoulos K; Pazaitou-Panayiotou K
Rare Tumors; 2015 May; 7(2):5765. PubMed ID: 26266011
[TBL] [Abstract][Full Text] [Related]
20. A Painful Periumbilical Nodule in a Reproductive-aged Woman.
Immaneni S; Delgado F; Baucom M
Indian J Dermatol; 2023; 68(6):729. PubMed ID: 38371561
[No Abstract] [Full Text] [Related]
[Next] [New Search]